BioAdvance News

QR Pharma Announces Publication on Posiphen Clincial Trials Showing Promise

By WebmasterJuly 17, 2012November 1st, 2024No Comments

QR Pharma Announces Publication on Posiphen Clincial Trials Showing Promise
Read more here

Previous PostQR Pharma Announces the Start of a Phase I Clinical Study for Bisnorcymserine
Next PostTREVENTIS Corporation Scientific Founder, Named Sobey Chair in Alzheimer’s Disease Research